デフォルト表紙
市場調査レポート
商品コード
1475822

臨床検査サービスの世界市場規模調査&予測、検査タイプ別、サービスプロバイダー別、用途別、地域別分析、2023年~2030年

Global Clinical Laboratory Service Market Size Study & Forecast, By Test Type By Service Provider, By Application and Regional Analysis, 2023-2030


出版日
ページ情報
英文 200 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.32円
臨床検査サービスの世界市場規模調査&予測、検査タイプ別、サービスプロバイダー別、用途別、地域別分析、2023年~2030年
出版日: 2024年04月30日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床検査サービスは、血液、尿、組織検体、その他の体液などの臨床検体に対して、疾病や病状の診断、モニタリング、治療を補助するために行われる幅広い診断および検査手順を包含します。

これらのサービスは臨床検査室によって提供され、臨床検査室は病院、ヘルスケア施設、独立診断検査室、または基準検査室の一部です。臨床検査室での検査は、病原体の存在の特定、バイオマーカーや分析物のレベルの測定、臓器機能の評価、治療効果のモニタリング、遺伝子異常の検出など、患者ケアに不可欠な情報を医療提供者に提供することにより、ヘルスケアにおいて重要な役割を果たしています。臨床検査サービス市場は、慢性疾患や感染症の有病率の増加、個別化医療の重視の高まり、ヘルスケア支出の増加などの要因により拡大しています。

市場を牽引しているのは、慢性疾患や感染症の急増と、精密かつ早期な疾患検出技術に対するニーズの高まりです。感染症や慢性疾患の世界の負担は増加傾向にあり、慢性疾患や微生物病原体に関連するさまざまなバイオマーカーを同定・特定する信頼性の高い手段として、臨床診断検査への需要が高まっています。この需要は、がんや結核のような疾病の蔓延の高まりと連動して強まっています。例えば、世界保健機関(WHO)の最近のデータでは、結核の世界的有病率は驚異的で、2021年時点で約1,000万人が罹患しており、その内訳は男性560万人、女性330万人、子供110万人となっています。このような疾患の持続的な高い有病率は、臨床サービスへの需要の急増を促し、それによって市場の成長を促進すると予想されます。さらに、がんの負担が増加していることから、臨床診断の必要性がさらに高まると予測されています。Globocan Statistics 2020で明らかなように、世界では男女を問わず1,930万人の新規がん症例が記録されており、がんの罹患率は世界規模で急速に高まっています。予測によれば、男女を問わず新たに発生するがん患者数は、2040年までに推定3,020万人に急増します。加えて、臨床検査における技術的進歩の高まりと、地理的拡大戦略の増加が、市場成長の新たな機会を生み出しています。しかし、厳しい規制要件や基準、ポイントオブケア検査(POCT)機器の普及が、2023~2030年の予測期間を通じて市場の成長を阻害しています。

臨床検査サービスの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、慢性疾患の高い有病率、確立されたヘルスケアインフラ、高齢者人口の増加により、2022年の市場を独占しました。この地域は、強固なヘルスケアシステムと臨床検査サービスに対する包括的な償還の枠組みから利益を得ています。さらに、この事業の魅力が新規参入企業の市場参入につながっています。例えば、2023年2月、オランダのバイオテクノロジー企業Detact Diagnostics社は、2年間のレンタル契約に基づき、キーン州立大学(米国)に新たな検査室を設立することを発表しました。さらに、アジア太平洋地域は予測期間中に最も速い速度で成長すると予想されています。その主な理由は、科学研究の増加、アンメットメディカルニーズへの対応、経済拡大、ヘルスケアインフラと規制枠組みの強化です。さらに、一般市民の意識の高まりと先進医療へのアクセスのしやすさが、同地域の成長をさらに促進すると予想されます。臨床検査サービスの重要性は、COVID-19のパンデミックの間、検査需要の高まりから拡大しました。主要な業界プレーヤーは、アジア太平洋地域の進化する市場ニーズに対応するため、戦略的に提携して革新的な臨床検査サービスを導入しています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も掲載しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の臨床検査サービス市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 臨床検査サービスの世界市場力学

  • 臨床検査サービス市場の影響分析(2020年~2030年)
    • 市場促進要因
      • 慢性疾患と感染症の有病率の増加
      • 個別化医療の重視の高まり
      • ヘルスケア支出の増加
    • 市場の課題
      • 厳しい規制要件と基準
      • ポイント・オブ・ケア検査(POCT)機器の人気の高まり
    • 市場機会
      • 臨床検査における技術進歩の高まり
      • 地理的拡大戦略の増加

第4章 世界の臨床検査サービス市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 臨床検査サービスの世界市場:検査タイプ別

  • 市場スナップショット
  • 臨床検査サービスの世界市場:検査タイプ別、実績 - ポテンシャル分析
  • 臨床検査サービスの世界市場:検査タイプ別推定・予測、2020年~2030年
  • 臨床検査サービス市場、サブセグメント分析
    • 遺伝子検査
    • 臨床化学検査
    • 医療微生物検査
    • 血液学検査
    • 免疫学検査
    • 細胞学検査
    • 乱用薬物検査
    • その他の検査

第6章 臨床検査サービスの世界市場:サービスプロバイダー別

  • 市場スナップショット
  • 臨床検査サービスの世界市場:サービスプロバイダー別、実績 - ポテンシャル分析
  • 臨床検査サービスの世界市場、サービスプロバイダー別推定・予測、2020年~2030年
  • 臨床検査サービス市場、サブセグメント分析
    • 病院ベースの検査室
    • 独立型検査室
    • クリニックベースの検査室

第7章 臨床検査サービスの世界市場:用途別

  • 市場スナップショット
  • 臨床検査サービスの世界市場:用途別実績-ポテンシャル分析
  • 臨床検査サービスの世界市場、用途別推定・予測、2020年~2030年
  • 臨床検査サービス市場、サブセグメント分析
    • バイオ分析・ラボ化学サービス
    • 毒物検査サービス
    • 細胞・遺伝子治療関連サービス
    • 前臨床試験・臨床試験関連サービス
    • 創薬・医薬品開発関連サービス
    • その他の臨床検査サービス

第8章 臨床検査サービスの世界市場、地域分析

  • 主要国
  • 新興国
  • 臨床検査サービス市場、地域別市場スナップショット
  • 北米
    • 米国
      • 検査タイプの推定・予測、2020年~2030年
      • サービスプロバイダー別の推定・予測、2020年~2030年
      • 用途別の推定・予測、2020年~2030年
    • カナダ
  • 欧州の臨床検査サービス市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の臨床検査サービス市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの臨床検査サービス市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東・アフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Laboratory Corporation of America Holdings(LabCorp)
      • 主要情報
      • 概要
      • 財務(データの入手可能性によります)
      • 製品概要
      • 最近の動向
    • QIAGEN NV
    • Eurofins Scientific SE
    • Quest Diagnostics Incorporated
    • OPKO Health, Inc.
    • Siemens Medical Solutions USA, Inc.
    • NeoGenomics Laboratories
    • Fresenius Medical Care
    • ARUP Laboratories
    • Sonic Healthcare

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1.Global Clinical Laboratory Service Market, report scope
  • TABLE 2.Global Clinical Laboratory Service Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3.Global Clinical Laboratory Service Market estimates & forecasts by Test Type 2020-2030 (USD Billion)
  • TABLE 4.Global Clinical Laboratory Service Market estimates & forecasts by Service Provider 2020-2030 (USD Billion)
  • TABLE 5.Global Clinical Laboratory Service Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 6.Global Clinical Laboratory Service Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7.Global Clinical Laboratory Service Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8.Global Clinical Laboratory Service Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9.Global Clinical Laboratory Service Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10.Global Clinical Laboratory Service Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11.Global Clinical Laboratory Service Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12.Global Clinical Laboratory Service Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13.Global Clinical Laboratory Service Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14.Global Clinical Laboratory Service Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15.Global Clinical Laboratory Service Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16.U.S. Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17.U.S. Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18.U.S. Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19.Canada Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20.Canada Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21.Canada Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22.UK Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23.UK Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24.UK Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25.Germany Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26.Germany Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27.Germany Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28.France Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29.France Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30.France Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31.Italy Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32.Italy Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33.Italy Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34.Spain Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35.Spain Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36.Spain Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37.RoE Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38.RoE Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39.RoE Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40.China Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41.China Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42.China Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43.India Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44.India Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45.India Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46.Japan Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47.Japan Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48.Japan Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49.South Korea Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50.South Korea Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51.South Korea Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52.Australia Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53.Australia Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54.Australia Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55.RoAPAC Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56.RoAPAC Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57.RoAPAC Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58.Brazil Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59.Brazil Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60.Brazil Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61.Mexico Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62.Mexico Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63.Mexico Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64.RoLA Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65.RoLA Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66.RoLA Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67.Saudi Arabia Clinical Laboratory Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68.South Africa Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69.RoMEA Clinical Laboratory Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70.List of secondary sources, used in the study of Global Clinical Laboratory Service Market
  • TABLE 71.List of primary sources, used in the study of Global Clinical Laboratory Service Market
  • TABLE 72.Years considered for the study
  • TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Clinical Laboratory Service Market, research methodology
  • FIG 2.Global Clinical Laboratory Service Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Clinical Laboratory Service Market, key trends 2022
  • FIG 5.Global Clinical Laboratory Service Market, growth prospects 2023-2030
  • FIG 6.Global Clinical Laboratory Service Market, porters 5 force model
  • FIG 7.Global Clinical Laboratory Service Market, pest analysis
  • FIG 8.Global Clinical Laboratory Service Market, value chain analysis
  • FIG 9.Global Clinical Laboratory Service Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10.Global Clinical Laboratory Service Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11.Global Clinical Laboratory Service Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12.Global Clinical Laboratory Service Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13.Global Clinical Laboratory Service Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14.Global Clinical Laboratory Service Market, regional snapshot 2020 & 2030
  • FIG 15.North America Clinical Laboratory Service Market 2020 & 2030 (USD Billion)
  • FIG 16.Europe Clinical Laboratory Service Market 2020 & 2030 (USD Billion)
  • FIG 17.Asia Pacific Clinical Laboratory Service Market 2020 & 2030 (USD Billion)
  • FIG 18.Latin America Clinical Laboratory Service Market 2020 & 2030 (USD Billion)
  • FIG 19.Middle East & Africa Clinical Laboratory Service Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Clinical Laboratory Service Market is valued at approximately USD 225.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Clinical laboratory services encompass a broad range of diagnostic and testing procedures performed on clinical specimens, such as blood, urine, tissue samples, and other bodily fluids, to aid in the diagnosis, monitoring, and treatment of diseases and medical conditions. These services are provided by clinical laboratories, which may be part of hospitals, healthcare facilities, independent diagnostic laboratories, or reference laboratories. Clinical laboratory testing plays a critical role in healthcare by providing healthcare providers with essential information for patient care, including identifying the presence of pathogens, measuring levels of biomarkers or analytes, assessing organ function, monitoring treatment effectiveness, and detecting genetic abnormalities. The Clinical Laboratory Service market is expanding because of factors such as the increasing prevalence of chronic and infectious diseases, growing emphasis on personalized medicine, and rising healthcare expenditure.

The market is driven by a surge in chronic and infectious diseases and an escalating need for precise and early disease detection techniques. The global burden of infectious diseases and chronic conditions is on the rise, amplifying demand for clinical diagnostic tests as a reliable means to identify and delineate various biomarkers associated with chronic ailments and microbial pathogens. This demand intensifies in tandem with the mounting prevalence of diseases like cancer and tuberculosis (TB). For example, recent data from the World Health Organization (WHO) reveals a staggering global tuberculosis prevalence, with approximately 10 million individuals affected as of 2021, encompassing 5.6 million men, 3.3 million women, and 1.1 million children. The persistent high prevalence of such diseases is anticipated to drive an upsurge in demand for clinical services, thereby fostering market growth. Moreover, the escalating burden of cancer is projected to further propel the need for clinical diagnostics. As evidenced by the Globocan Statistics 2020, there were 19.3 million new cancer cases recorded worldwide, encompassing both genders, with the incidence of cancer rapidly escalating on a global scale. Projections indicate that the number of new cancer cases across genders will soar to an estimated 30.2 million by the year 2040. In addition, rising technological advancement in clinical testing and a growing number of geographical expansion strategies are creating new opportunities for market growth. However, stringent regulatory requirements and standards and the growing popularity of point-of-care testing (POCT) devices stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Laboratory Service Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing high prevalence of chronic diseases, a well-established healthcare infrastructure, and a growing geriatric population. The region benefits from a robust healthcare system and a comprehensive reimbursement framework for clinical laboratory services. Additionally, the attractiveness of the business has led to the entry of new players into the market. For example, in February 2023, Dutch biotech company Detact Diagnostics announced the establishment of a new laboratory at Keene State College (U.S.) under a 2-year rental contract. Furthermore, Asia Pacific is expected to grow at the fastest rate during the forecast period, primarily attributed to the rise in scientific research, addressing unmet medical needs, economic expansion, and enhancements in healthcare infrastructure and regulatory frameworks. Moreover, increasing public awareness and the accessibility of advanced medical treatments are expected to further drive growth in the region. The significance of clinical laboratory services has been magnified during the COVID-19 pandemic, given the heightened demand for testing. Major industry players are strategically partnering to introduce innovative laboratory testing services to meet evolving market needs in the Asia Pacific region.

Major market players included in this report are:

  • Laboratory Corporation of America Holdings (LabCorp)
  • QIAGEN NV
  • Eurofins Scientific SE
  • Quest Diagnostics Incorporated
  • OPKO Health, Inc.
  • Siemens Medical Solutions USA, Inc.
  • NeoGenomics Laboratories
  • Fresenius Medical Care
  • ARUP Laboratories
  • Sonic Healthcare

Recent Developments in the Market:

  • In August 2023, Laboratory Corporation of America Holdings (Labcorp) finalized an agreement with Tufts Medicine to acquire Tufts Medicine Outreach Laboratory Business. This acquisition aims to broaden Labcorp's diagnostic testing and laboratory services offerings.
  • In February 2023, Dutch biotech company Detact Diagnostics disclosed plans to establish a new laboratory at Keene State College (U.S.) through a two-year rental agreement.

Global Clinical Laboratory Service Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Test Type, Service Provider, Application, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Test Type:

  • Genetic Testing
  • Clinical Chemistry
  • Medical Microbiology Testing
  • Hematology Testing
  • Immunology Testing
  • Cytology Testing
  • Drug of Abuse Testing
  • Other Esoteric Tests

By Service Provider:

  • Hospital-based Laboratories
  • Stand-alone Laboratories
  • Clinic-based Laboratories

By Application:

  • Bioanalytical & Lab Chemistry Services
  • Toxicology Testing Services
  • Cell & Gene Therapy Related Services
  • Preclinical & Clinical Trial Related Services
  • Drug Discovery & Development Related Services
  • Other Clinical Laboratory Services

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1.Clinical Laboratory Service Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2.Clinical Laboratory Service Market, by Test Type, 2020-2030 (USD Billion)
    • 1.2.3.Clinical Laboratory Service Market, by Service Provider, 2020-2030 (USD Billion)
    • 1.2.4.Clinical Laboratory Service Market, by Application, 2020-2030 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Clinical Laboratory Service Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Clinical Laboratory Service Market Dynamics

  • 3.1.Clinical Laboratory Service Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Increasing Prevalence of Chronic and Infectious Diseases
      • 3.1.1.2.Growing Emphasis on Personalized Medicine
      • 3.1.1.3.Rising Healthcare Expenditure
    • 3.1.2.Market Challenges
      • 3.1.2.1.Stringent Regulatory Requirements and Standards
      • 3.1.2.2.Growing Popularity of Point-Of-Care Testing (POCT) Devices
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Rising Technological Advancement in Clinical Testing
      • 3.1.3.2. Growing Number of Geographical Expansion Strategies

Chapter 4.Global Clinical Laboratory Service Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Clinical Laboratory Service Market, by Test Type

  • 5.1.Market Snapshot
  • 5.2.Global Clinical Laboratory Service Market by Test Type, Performance - Potential Analysis
  • 5.3.Global Clinical Laboratory Service Market Estimates & Forecasts by Test Type 2020-2030 (USD Billion)
  • 5.4.Clinical Laboratory Service Market, Sub Segment Analysis
    • 5.4.1. Genetic Testing
    • 5.4.2.Clinical Chemistry
    • 5.4.3.Medical Microbiology Testing
    • 5.4.4.Hematology Testing
    • 5.4.5.Immunology Testing
    • 5.4.6.Cytology Testing
    • 5.4.7.Drug of Abuse Testing
    • 5.4.8.Other Esoteric Tests

Chapter 6.Global Clinical Laboratory Service Market, by Service Provider

  • 6.1.Market Snapshot
  • 6.2.Global Clinical Laboratory Service Market by Service Provider, Performance - Potential Analysis
  • 6.3.Global Clinical Laboratory Service Market Estimates & Forecasts by Service Provider 2020-2030 (USD Billion)
  • 6.4.Clinical Laboratory Service Market, Sub Segment Analysis
    • 6.4.1. Hospital-based Laboratories
    • 6.4.2.Stand-alone Laboratories
    • 6.4.3.Clinic-based Laboratories

Chapter 7.Global Clinical Laboratory Service Market, by Application

  • 7.1.Market Snapshot
  • 7.2.Global Clinical Laboratory Service Market by Application, Performance - Potential Analysis
  • 7.3.Global Clinical Laboratory Service Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 7.4.Clinical Laboratory Service Market, Sub Segment Analysis
    • 7.4.1. Bioanalytical & Lab Chemistry Services
    • 7.4.2.Toxicology Testing Services
    • 7.4.3.Cell & Gene Therapy Related Services
    • 7.4.4.Preclinical & Clinical Trial Related Services
    • 7.4.5.Drug Discovery & Development Related Services
    • 7.4.6.Other Clinical Laboratory Services

Chapter 8.Global Clinical Laboratory Service Market, Regional Analysis

  • 8.1.Top Leading Countries
  • 8.2.Top Emerging Countries
  • 8.3.Clinical Laboratory Service Market, Regional Market Snapshot
  • 8.4.North America Clinical Laboratory Service Market
    • 8.4.1.U.S. Clinical Laboratory Service Market
      • 8.4.1.1.Test Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2.Service Provider breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.2.Canada Clinical Laboratory Service Market
  • 8.5.Europe Clinical Laboratory Service Market Snapshot
    • 8.5.1.U.K. Clinical Laboratory Service Market
    • 8.5.2.Germany Clinical Laboratory Service Market
    • 8.5.3.France Clinical Laboratory Service Market
    • 8.5.4.Spain Clinical Laboratory Service Market
    • 8.5.5.Italy Clinical Laboratory Service Market
    • 8.5.6.Rest of Europe Clinical Laboratory Service Market
  • 8.6.Asia-Pacific Clinical Laboratory Service Market Snapshot
    • 8.6.1.China Clinical Laboratory Service Market
    • 8.6.2.India Clinical Laboratory Service Market
    • 8.6.3.Japan Clinical Laboratory Service Market
    • 8.6.4.Australia Clinical Laboratory Service Market
    • 8.6.5.South Korea Clinical Laboratory Service Market
    • 8.6.6.Rest of Asia Pacific Clinical Laboratory Service Market
  • 8.7.Latin America Clinical Laboratory Service Market Snapshot
    • 8.7.1.Brazil Clinical Laboratory Service Market
    • 8.7.2.Mexico Clinical Laboratory Service Market
  • 8.8.Middle East & Africa Clinical Laboratory Service Market
    • 8.8.1.Saudi Arabia Clinical Laboratory Service Market
    • 8.8.2.South Africa Clinical Laboratory Service Market
    • 8.8.3.Rest of Middle East & Africa Clinical Laboratory Service Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1. Laboratory Corporation of America Holdings (LabCorp)
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Recent Developments
    • 9.3.2. QIAGEN NV
    • 9.3.3.Eurofins Scientific SE
    • 9.3.4.Quest Diagnostics Incorporated
    • 9.3.5.OPKO Health, Inc.
    • 9.3.6.Siemens Medical Solutions USA, Inc.
    • 9.3.7.NeoGenomics Laboratories
    • 9.3.8.Fresenius Medical Care
    • 9.3.9.ARUP Laboratories
    • 9.3.10.Sonic Healthcare

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes
  • 10.3.Research Assumption